Climate Change Data

Environmental Metrics

ESG Focus Areas

• Child Health
• Sustainable Livelihoods

Environmental Achievements

• Planted around 4300 saplings at manufacturing locations and R&D centers.

Social Achievements

• Impacted over 8000 individuals with sustainable livelihoods.
• Over 750 employees volunteered services with various NGOs.
• Rehabilitated approximately 2800 differently-abled individuals through Jaipur Foot.
• Donated around Rs 2.9 million worth of medicines to various partners.

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• High Child Mortality Rate (CMR) and Infant Mortality Rate (IMR) in India.
• High levels of malnutrition, lack of sanitation, and inadequate immunization in various regions.
• Poverty and lack of opportunities leading to unskilled labor among youth.

Mitigation Strategies

• Project Kavach: Focused on child health in tribal areas of Madhya Pradesh, rural Rajasthan, and Mumbai slums.
• Project Sambhav: Provided vocational training and employment opportunities to school dropouts.
• Project Jode: Focused on sustainable livelihoods for tribal populations in Rayagada, Odisha.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Child Health
• Sustainable Livelihoods
• Environment, Health and Safety
• Employee Volunteering

Environmental Achievements

• Reduced specific water consumption by more than 30% compared to the previous year.
• Reduced specific effluent quantities by more than 18% compared to 2012-13.
• Goa, Nashik, Ankleshwar, Dahej and Aurangabad plants achieved zero liquid discharge outside plant premises.
• ISO 14001:2004 standard implemented at Nashik and Indore plants; recertification achieved at Goa plant.
• Goa plant started co-processing of rejected medicine.

Social Achievements

• Positively impacted over 500,000 lives through child health initiatives.
• Made a difference to over 65,000 lives with sustainable livelihood initiatives.
• Over 3,200 employees volunteered more than 12,800 hours in community endeavors.
• Donated medicines worth USD 600,000 to charitable organizations.
• Rehabilitated over 2,000 differently-abled individuals by providing artificial limbs.

Governance Achievements

• Implemented ISO 14001:2004 at multiple plants.
• Developed 60 Standard Operating Procedures (SOPs) under the Safety Management Systems.
• Established safety systems at all Glenmark plants.
• Glenmark was ranked among India’s 50 Most Caring Companies by the World CSR Congress, 2014.

Climate Goals & Targets

Environmental Challenges

• High infant and child mortality rates in rural and tribal regions.
• Malnutrition among children in both rural and urban areas.
• Limited access to essential medicines in public health facilities.
• Lack of livelihood opportunities for school dropouts and marginalized communities.
• Geographical constraints and scarce infrastructure in rural areas.

Mitigation Strategies

• Implemented Project Kavach focusing on nutrition, sanitation, and immunization.
• Launched mMitra, a mobile voice messaging service for pregnant women and mothers.
• Provided vocational training and skill development programs.
• Improved land and water resources for tribal farmers.
• Provided ambulatory care services and established role model Anganwadis.

Supply Chain Management

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• SDG 3: Good Health and Well-being
• SDG 1: No Poverty
• SDG 2: Zero Hunger
• SDG 6: Clean Water and Sanitation

Glenmark's initiatives contribute to these goals through improved child health, sustainable livelihoods, and environmental protection.

Awards & Recognition

• GreenTech Environment Award – 2013 (Goa plant)

Environmental Metrics

ESG Focus Areas

• Managing our carbon emissions
• Promoting diversity
• Community engagement
• Impact of climate change on health
• Energy efficiency
• Waste management
• Water management
• Enhancing availability and accessibility of medicines
• Employee health and safety
• Responsible supply chain
• Human resource development
• Promoting innovation
• Patient safety
• Business ethics
• Ensuring product quality
• Intellectual property rights
• Compliance and risk management

Environmental Achievements

• 75% of manufacturing facilities are ISO 14001:2015 certified
• 119 MT of hazardous waste co-processed
• 3% Renewable source of electrical energy
• 5.8% drop in specific energy consumption compared to the previous reporting period.
• Net cost saving of 46.44 Million and energy saving of 59,589 GJ from energy conservation efforts.

Social Achievements

• 1.4 Million Lives touched through CSR interventions
• 69,062 Man-hours number of EHS training hours
• 3% increase in our women workforce strength
• Zero cases of occupational disease or fatalities

Governance Achievements

• 25% female representation at the board level
• Implemented an Enterprise Risk Management (ERM) program

Climate Goals & Targets

Environmental Challenges

• Delivering commercially successful new products
• Ensuring product quality
• Supply chain continuity
• Product pricing
• Compliance with relevant laws and regulations
• Changing global political and economic conditions
• Compliance with financial reporting and disclosure requirements
• Compliance with tax law
• Compliance with anti-bribery and corruption legislation
• Potential litigation
• Product liability litigation
• Sales and marketing litigation
• Managing environmental, health, safety and sustainability
• Information technology
• Revenue concentration

Mitigation Strategies

• Adopted R&D business model based on smaller units
• Adopted a single Quality Management System (QMS)
• High revenue and critical products are heavily stocked
• Dual sourcing for critical units
• Internal Control Framework (ICF)
• Regular review of tax policies
• Anti-Bribery/Anti-Corruption (ABAC) policy
• Proactive risk/dispute management
• Data security measures
• Project management team oversees short and long-term needs

Supply Chain Management

Supplier Audits: Every 3 years for all API suppliers

Responsible Procurement

• Supplier code of conduct

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather events

Transition Risks

• Changing regulatory landscape

Opportunities

• Shifting to renewable energy sources

Reporting Standards

Frameworks Used: GRI Standards: Core option

Certifications: ISO 14001:2015, OHSAS 18001:2007

Third-party Assurance: Bureau Veritas (India) Private Limited

UN Sustainable Development Goals

• Goal 3: Good Health and Well-being
• Goal 6: Clean Water and Sanitation
• Goal 7: Affordable and Clean Energy
• Goal 8: Decent Work and Economic Growth
• Goal 9: Industry, Innovation and Infrastructure
• Goal 10: Reduced Inequalities
• Goal 11: Sustainable Cities and Communities
• Goal 12: Responsible Consumption and Production
• Goal 13: Climate Action

Glenmark's CSR initiatives are aligned with these SDGs.

Awards & Recognition

• Golden Peacock Award for Innovative Business Leadership, 2018
• CII safety, health and environmental excellence & innovation award, 2018
• Greentech Environment Award, 2018
• Greentech Safety Award, 2018
• Safety award by Grow Care, 2018
• Featured in the 4th Annual Inclusive Business List 2018
• Featured in the 2nd edition of ETChallenger2Good

Environmental Metrics

ESG Focus Areas

• Business Ethics
• Corporate Governance
• Cybersecurity & Data Privacy
• Product Quality & Safety
• Human Capital & Development
• Enhancing Accessibility of Medicines
• Climate Change
• Talent Attraction & Retention
• Human Rights
• Occupational Health & Safety
• Supply Chain Management
• Circular Economy
• Risk Management
• Community Development
• Innovation & Research
• Promoting Diversity
• Policy Advocacy

Environmental Achievements

• Reduced carbon emission intensity by around 10% through efforts over the last three years
• 6% of total energy consumption is from renewable energy sources
• 61% of the energy requirements at both the R&D sites are met by renewable energy source (hydro-power)
• 58% of total hazardous waste disposed of in FY 2023 was co-processed
• 6 out of 10 Indian sites achieved ‘Zero Waste to Landfill’ objective

Social Achievements

• Great Place to Work™ (GPTW) Institute certified as a Great Place to Work in 2023-24
• Impacted more than 2.9 million lives through CSR programs
• Launched CSR employee volunteering campaign
• India’s first Indacaterol + Mometasone Fixed-Dose Combination (FDC) Drug for Asthma launched
• India’s first triple Fixed-Dose Combination (FDC) of Teneligliptin + Pioglitazone + Metformin launched
• Sitagliptin and its Fixed-Dose Combinations (FDC) launched at affordable price for adults with Type 2 diabetes in India
• Sacu V™, a Fixed-Dose Combination (FDC) of Sacubitril + Valsartan, launched, making heart failure treatment more affordable in India

Governance Achievements

• Independent directors comprise over 65% of the board
• Strengthened Compliance Program in 2022 with enhancements including a new Code of Conduct, revised training framework, EthicsLine launch, and strengthened risk assessment and mitigation efforts
• Launched Glenmark EthicsLine, a confidential reporting line

Climate Goals & Targets

Environmental Challenges

• Risk associated with R&D not always being able to deliver Commercially Successful Products
• Risk of supply chain disruptions
• Risk of Revenue Concentration
• External risks: natural disasters, political events and economic fluctuations
• Risks associated with Inadequate Cyber Security and Data Privacy Measures
• Risk associated with Inferior Product Quality
• Risk of sub-optimal product pricing
• Risk of Product Liability Litigation
• Risk associated with Non-Compliance in Financial Reporting and Disclosure, and Changes to Accounting Standards
• Risk of Non-Compliance with International Laws and Regulations
• Risk of Anti-Bribery and Corruption Legislation
• Risk of Potential Litigation
• Risk of Non-Compliance with Tax Laws
• Risk of Non-Compliance with EHS and Sustainability Laws

Mitigation Strategies

• Smaller R&D units to encourage greater entrepreneurialism and accountability, collaborations with other pharmaceutical companies
• Diversification of the supply chain, safety stocks and backup supply arrangements, new manufacturing facilities/upgraded existing facilities
• Product development strategy to deliver desired products timely, replace end-of-life cycle products, penetrate new markets
• Diversity of portfolio and geographic footprint, market tools to manage currency risk exposure, Climate Risk Assessment, diversifying supplier base
• Strong cyber security infrastructure, risk-aware culture, compliance with data privacy laws, insurance cover
• Central Quality Management System (ISO accreditation), strict audit mechanisms for third-party suppliers
• Optimize product costs, launch new value-added products
• Rigorous testing and quality control, clear warnings, instructions, and labels
• Working with external auditor and advisors to ensure adherence to relevant reporting requirements
• Internal control framework to monitor and support compliance, Head of Regulatory affairs ensures adherence to internal standards
• New Code of Conduct and ABAC policy, mandatory ABAC training
• Formalized processes for proactive risk/dispute management
• Policy to submit tax returns within statutory time limits, engage with tax authorities, legal counsel to review tax legislation
• Embedded EHSS risk management, rigorous procedures to eliminate hazards, manage environmental remediation obligations

Supply Chain Management

Supplier Audits: 23 new raw material suppliers and 27 new packaging material suppliers assessed in FY23; 14 third-party assessments conducted

Responsible Procurement

• Supplier Code of Conduct
• Supplier sustainability protocol aligned to PSCI requirements

Climate-Related Risks & Opportunities

Physical Risks

• Rise in global temperatures leading to lower productivity, increased energy demand, water scarcity, damage to infrastructure from extreme weather
• Cyclonic activities, flooding and extreme weather conditions

Transition Risks

• Carbon tax, increased operational costs, decreased revenue, competitor cost advantages, supply chain disruptions

Opportunities

• Increased demand for immunology products due to warmer temperatures

Reporting Standards

Frameworks Used: GRI Standards

Certifications: ISO 14001:2015, ISO 45001:2018

Third-party Assurance: DNV GL Business Assurance India Private Limited

UN Sustainable Development Goals

• 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 13, 15, 16, 17

CSR initiatives aligned with UN SDGs

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Great Place to Work™ certification
• #3 in Businessworld's pharmaceutical and healthcare sector ranking
• Economic Times recognition